MoonLake Immunotherapeutics
MLTX
#3468
Rank
$3.23 B
Marketcap
$51.24
Share price
2.86%
Change (1 day)
20.10%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -$78.41 Million USD

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$54.13 Million USD, an increase over its 2022 earnings that were of -$65.07 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$78.41 Million44.86%
2023 -$54.13 Million-16.81%
2022 -$65.07 Million